Out-of-hospital opioid therapy of palliative care patients with "acute dyspnoea": A retrospective multicenter investigation

Journal of Opioid Management

Volumn 5, Issue 2, 2009, Pages 115-122

  Wiese, Christoph H R ^a   Bartels, Utz E ^b   Graf, Bernhard M ^c   Hanekop, Gerd G ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b University Medical Centre   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Palliative emergency; Prehospital emergency care; Respiratory depression; Symptom control

Indexed keywords

BENZODIAZEPINE; BRONCHODILATING AGENT; MORPHINE; OXYGEN;

ABSENCE OF SIDE EFFECTS; ACUTE DYSPNEA; ADULT; AGED; ARTICLE; BREATHING RATE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DYSPNEA; EMERGENCY CARE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; OXYGEN THERAPY; PALLIATIVE THERAPY; RETROSPECTIVE STUDY;

EID: 65749106948     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2009.0013     Document Type: Article

References (44)

1. Currow DC, Ward AM, Plummer JL, et al.: Comfort in the last 2 weeks of life: Relationship to accessing palliative care services. Supp Care Cancer. 2008; 16: 1255-1263.
2. Ensink FB, Bautz MT, Hanekop GG: Improvement of palliative outpatient treatment of terminally ill cancer patients - SUPPORT as example - The ethically preferable alternative to euthanasia. Anaesthesiol Intensivmed Notfallmed Schmerzther. 2001; 36: 530-537.
3. Hanekop GG, Kriegler M, Görlitz A, et al.: Ambulant Palliative Medicine. Stuttgart, New York: Schattauer, 2003: S66-S79.
4. Schindler T, Ewald H: Out-of-hospital and in-hospital structures in palliative medicine. Onkologe. 2005; 11: 376-383.
5. Nauck F: Symptom control in the final stage of disease. Schmerz. 2001; 15: 362-369.
6. Clemens KE, Klaschik E: Symptomatic therapy of dyspnoea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage. 2007; 33: 473-481.
7. Clemens KE, Quednau I, Klaschik E: Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: A prospective study. Support Care Cancer. 2009; 17: 367-377.
8. Donnelly S, Walsh D: The symptoms of advanced cancer. Sem Oncol. 1995; 22(2 Suppl 3): 67-72.
9. Dudgeon DJ: Managing dyspnoea and cough. Hematol Oncol Clin N Am. 2002; 16: 557-577.
10. Elia G, Thomas J: The symptomatic relief of dyspnoea. Curr Oncol Rep. 2008; 10: 319-325.
11. Viola R, Kitely C, Lloyd NS, et al.: The management of dyspnoea in cancer patients: A systematic review. Support Care Cancer. 2008; 16: 329-337.
12. Williams CM: Dyspnoea. Cancer J. 2006; 12: 365-373.
13. Thomas JR, von Gunten CF: Treatment of dyspnoea in cancer patients. Oncology. (Williston Park) 2002; 16: 745-750.
14. Gugger M, Bachofen H: Dyspnoea: Basic principles and pathophysiology. SchweizMed Forum No. 6, 2001.
15. Bausewein C, Farquhar M, Booth S, et al.: Measurement of breathlessness in advanced disease: A systematic review. Respir Med. 2007; 101: 399-410.
16. Dorman C, Byrne A, Edwards A: Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med. 2007; 21: 177-191.
17. Vainic, A, Auvinen A, Symptom Prevalence Group: Prevalence of symptoms among patients with advanced cancer: An international collaborative study. J Pain Symptom Manage. 1996; 12: 3-10.
18. Wiese C, Bartels U, Ruppert D, et al.: Treatment of oncology patients in the final stadium of disease by prehospital emergency physicians. Anaesthesist. 2007; 56: 133-140.
19. Wright AA, Zhang B, Ray A, et al.: Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300: 1665-1673.
20. Salomon F: Decision conflicts in emergency medicine. Anaesthesiol Intensivmed Notfallmed Schmerzther. 2000; 35: 319-325.
21. Salomon F: Competence in palliative medicine for the emergency physician. Notfall Rettungsmed. 2005; 8: 542-547.
22. Salako SE: The declaration of Helsinki 2000: Ethical principles and the dignity of difference. Med Law. 2006; 25:341-354.
23. Maak CA, Tabas JA, McClintock TE: Should acute treatment with Inhaled Beta agonists be withheld from patients with dyspnoea who may have heart failure? J Emerg Med. 2008.
24. Pfeifer M: Dyspnoea. Pneumologe. 2005; 2: 177-187.
25. Wagner U, Vogelmeier C: Acute dyspnoea. Internist. 2005; 46: 965-973.
26. Groeben H: The acute severe asthma attack. Notfall Rettungsmed. 2005; 8: 67-77.
27. Miller AH, Nazeer S, Pepe P, et al.: Acutely decompensated heart failure in a county emergency department: A double-blind randomized controlled comparison of nesiritide versus placebo treatment. Ann Emerg Med. 2008; 51: 571-578.
28. Clemens KE, Klaschik E: Symptomatic treatment of dyspnoea in patients receiving palliative care: Nasal delivery of oxygen compared with opioid administration. Dtsch Med Wochenschr. 2007; 132: 1939-1943.
29. Johnson MA, Woodcock AA, Geddes DM: Dihydrocodeine for breathlessness in "pink puffers". Br Med J. 1983; 286: 675-677.
30. Rice KL, Kronenberg KS, Hedemark LL, et al.: Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. Br J Dis Chest. 1987; 81: 287-292.
31. Escalante CP, Martin CG, Eiting LS, et al.: Dyspnoea in cancer patients. Etiology, resource utilization, and survival - implications in a managed care world. Cancer. 1996; 78: 1314-1319.
32. Abernethy AP, Currow DC, Frith P, et al.: Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. Br Med J. 2003; 327: 523-526.
33. Bruera E, MacEachern T, Ripamonti C, et al.: Subcutaneous morphine for dyspnoea in cancer patients. Ann Intern Med. 1993; 119: 906-907.
34. Chua TP, Harrington D, Ponikowski P, et al.: Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiok. 1997; 29: 147-152.
35. Currow DC, Abernethy AP: Pharmacological management of dyspnoea. Curr Opin Support Palliat Care. 2007; 1: 96-101.
36. Mazzocato C, Buclin T, Rapin CH: The effects of morphine on dyspnoea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial. Ann Oncol. 1999; 10: 1511-1514.
37. Woodcock AA, Gross ER, Gellert A, et al.: Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med. 1981; 305: 1611-1616.
38. Cachia E, Ahmedzai SH: Breathlessness in cancer patients. Eur J Cancer. 2008; 44: 1116-1123.
39. Daud ML: Drug management of terminal symptoms in advanced cancer patients. Curr Opin Support Palliat Care. 2007; 1: 202-206.
40. Wiese CHR, Bartels U, Ruppert D, et al.: Treatment of palliative emergencies by emergency physicians in Germany. Palliat Med. 2009.
41. Wiese CHR, Vossen-Wellmarm A, Morgenthal HC, et al.: Emergency calls and need for emergency care in patients looked after by a palliative care team: Retrospective interview study with bereaved relatives. BMC Palliat Care. 2008; 7: 11.
42. Dick W: Anglo-American vs. Franco-German emergency medical services system. Prehosp Disaster Med. 2003; 18: 29-35.
43. Timmermann A, Russo SG, Hollmann MW: Paramedic versus emergency physician emergency medical service: Role of the anaesthesiologist and the European versus the Anglo-American concept. Curr Opin Anaesthesiol. 2008; 21: 222-227.
44. Wiese CHR, Bartels UE, Marezynska K, et al.: Quality of out-of-hospital palliative emergency care depends on the expertise of the emergency medical team - A prospective multi-centre analysis. Support Care Cancer. 2009 Mar 25.